X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3230) 3230
Book Review (1067) 1067
Publication (198) 198
Book / eBook (39) 39
Book Chapter (17) 17
Newspaper Article (11) 11
Newsletter (4) 4
Conference Proceeding (1) 1
Dissertation (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2751) 2751
humans (2575) 2575
oncology (1563) 1563
cancer (1308) 1308
female (1261) 1261
male (1246) 1246
middle aged (1093) 1093
aged (1003) 1003
adult (717) 717
carcinoma (607) 607
tumors (584) 584
prognosis (555) 555
animals (541) 541
chemotherapy (534) 534
lung cancer (526) 526
metastasis (515) 515
research (501) 501
care and treatment (471) 471
lung neoplasms - drug therapy (456) 456
biomarkers (448) 448
expression (441) 441
carcinoma, non-small-cell lung - drug therapy (434) 434
pharmacology & pharmacy (404) 404
diagnosis (398) 398
analysis (379) 379
medicine & public health (371) 371
lung neoplasms - pathology (368) 368
breast-cancer (353) 353
aged, 80 and over (348) 348
lung-cancer (325) 325
genetic aspects (318) 318
health aspects (313) 313
gene expression (310) 310
lung cancer, non-small cell (308) 308
antineoplastic agents - therapeutic use (289) 289
development and progression (287) 287
neoplasm staging (286) 286
treatment outcome (286) 286
proteins (284) 284
carcinoma, non-small-cell lung - pathology (280) 280
antineoplastic combined chemotherapy protocols - therapeutic use (267) 267
patients (263) 263
cell lung-cancer (262) 262
apoptosis (254) 254
hepatocellular-carcinoma (254) 254
survival (242) 242
bladder cancer (239) 239
medicine (237) 237
squamous-cell carcinoma (232) 232
medical prognosis (231) 231
gene expression regulation, neoplastic (230) 230
cancer research (226) 226
cancer therapies (226) 226
cell biology (225) 225
biochemistry & molecular biology (222) 222
review (215) 215
studies (214) 214
cell line, tumor (213) 213
mutation (207) 207
therapy (204) 204
prostate-cancer (203) 203
colorectal-cancer (201) 201
pathology (201) 201
neoplasms - drug therapy (192) 192
biomarkers, tumor - blood (189) 189
biomarkers, tumor - genetics (186) 186
metastases (184) 184
dna methylation (182) 182
medical research (182) 182
microrna (181) 181
non-small cell lung cancer (178) 178
respiratory system (178) 178
lung neoplasms - genetics (176) 176
angiogenesis (173) 173
drug therapy (173) 173
mice (173) 173
research article (173) 173
immunohistochemistry (172) 172
surgery (172) 172
biomarker (171) 171
lung neoplasms - metabolism (169) 169
risk factors (169) 169
medicine, research & experimental (167) 167
biomarkers, tumor - metabolism (165) 165
breast cancer (164) 164
squamous cell carcinoma (163) 163
cisplatin (161) 161
physiological aspects (160) 160
abridged index medicus (158) 158
oncology, experimental (158) 158
hematology, oncology and palliative medicine (156) 156
pharmacology/toxicology (153) 153
renal-cell carcinoma (152) 152
adenocarcinoma (151) 151
clinical trials (151) 151
genes (151) 151
lung neoplasms - diagnosis (151) 151
kinases (150) 150
micrornas (147) 147
survival rate (147) 147
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (28) 28
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Gerstein Science - Circulation Desk (3) 3
St. Michael's Hospital - Stacks (3) 3
Humber River Regional Hospital - Finch Stacks (2) 2
Markham Stouffville Hospital - Stacks (2) 2
St Josephs Health Centre - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Special Collections (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Storage (1) 1
Online Resources - Online (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Trillium Health Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3273) 3273
German (6) 6
Japanese (5) 5
Chinese (3) 3
Spanish (3) 3
Polish (2) 2
Arabic (1) 1
French (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 2, pp. 189 - 194
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 11/2015, Volume 76, Issue 5, pp. 989 - 996
Acute kidney injury (AKI) is a common and serious adverse effect of cisplatin-based chemotherapy. However, traditional markers of kidney function, such as... 
Biomarker | Medicine & Public Health | Acute kidney injury | Lung cancer | Oncology | Cancer Research | Pharmacology/Toxicology | Cisplatin | RAT | TOXICITY | GELATINASE-ASSOCIATED LIPOCALIN | COMBINATION | KIM-1 | ONCOLOGY | CARDIAC-SURGERY | PHARMACOLOGY & PHARMACY | RENAL INJURY | Acute Kidney Injury - urine | Acute-Phase Proteins - urine | Lung Neoplasms - drug therapy | Membrane Glycoproteins - urine | Biomarkers - urine | Lung Neoplasms - urine | Area Under Curve | Humans | Middle Aged | Proto-Oncogene Proteins - urine | Lipocalins - urine | Male | Vinblastine - administration & dosage | Neoplasm Proteins - urine | Cisplatin - administration & dosage | Carcinoma, Small Cell - urine | Vinblastine - analogs & derivatives | Female | Acute Kidney Injury - chemically induced | Receptors, Virus | Carcinoma, Small Cell - drug therapy | beta 2-Microglobulin - urine | Carcinoma, Squamous Cell - urine | Etoposide - administration & dosage | Hepatitis A Virus Cellular Receptor 1 | Adenocarcinoma - drug therapy | Creatinine - urine | Carcinoma, Non-Small-Cell Lung - urine | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemokine CCL2 - urine | Lipocalin-2 | Cisplatin - adverse effects | ROC Curve | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Antineoplastic Agents, Alkylating - adverse effects | Adenocarcinoma - urine | Proteins | Antimitotic agents | Evaluation | Care and treatment | Cancer patients | Chemotherapy | Analysis | Antineoplastic agents | Biological markers | Cancer | Index Medicus | lung cancer | acute kidney injury | cisplatin | biomarker
Journal Article
International Journal of Oncology, ISSN 1019-6439, 2009, Volume 34, Issue 6, pp. 1629 - 1636
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 04/2014, Volume 9, Issue 4, pp. 577 - 582
Cyclooxygenase-2 (COX-2) overexpression is associated with a poor prognosis in non–small-cell lung cancer (NSCLC) and may promote resistance to epidermal... 
Cyclooxygenase-2 inhibitor | Non–small-cell lung cancer | Apricoxib | Erlotinib | Prostaglandin E2 metabolite | Non-small-cell lung cancer | metabolite | Prostaglandin E | 1ST-LINE TREATMENT | CYCLOOXYGENASE-2 | COX-2 | TUMOR | OPEN-LABEL | CELECOXIB | CHEMOTHERAPY | EGFR | TRIAL | GROWTH-FACTOR RECEPTOR | ONCOLOGY | RESPIRATORY SYSTEM | Prostaglandin E-2 metabolite | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Adenocarcinoma - pathology | Lung Neoplasms - urine | Prognosis | Prospective Studies | Follow-Up Studies | Adenocarcinoma, Bronchiolo-Alveolar - pathology | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Adenocarcinoma, Bronchiolo-Alveolar - mortality | Lung Neoplasms - pathology | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Carcinoma, Squamous Cell - mortality | Biomarkers, Tumor - urine | Prostaglandins - urine | Cyclooxygenase 2 Inhibitors - therapeutic use | Aged, 80 and over | Adult | Female | Pyrroles - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Double-Blind Method | Antineoplastic Combined Chemotherapy Protocols | Neoplasm Recurrence, Local - urine | Carcinoma, Squamous Cell - urine | Survival Rate | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Carcinoma, Non-Small-Cell Lung - urine | Carcinoma, Squamous Cell - drug therapy | Sulfonamides - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Adenocarcinoma, Bronchiolo-Alveolar - drug therapy | Adenocarcinoma - mortality | Adenocarcinoma - urine | Adenocarcinoma, Bronchiolo-Alveolar - urine | Index Medicus
Journal Article
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 05/2010, Volume 19, Issue 5, pp. 1362 - 1372
Journal Article
Cancer Prevention Research, ISSN 1940-6207, 02/2015, Volume 8, Issue 2, pp. 111 - 119
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2015, Volume 76, Issue 1, pp. 117 - 124
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 10/2010, Volume 15, Issue 5, pp. 484 - 488